vs

Side-by-side financial comparison of Dexcom (DXCM) and WATSCO INC (WSO). Click either name above to swap in a different company.

WATSCO INC is the larger business by last-quarter revenue ($1.6B vs $1.3B, roughly 1.3× Dexcom). Dexcom runs the higher net margin — 21.2% vs 4.5%, a 16.7% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs -10.0%). Over the past eight quarters, Dexcom's revenue compounded faster (12.0% CAGR vs 0.4%).

Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.

Watsco, Inc. is a distributor of air conditioning, heating and refrigeration equipment, and related parts and supplies (HVAC/R) in the United States. Watsco was founded more than 60 years ago as a manufacturer of parts, components, and tools used in the HVAC/R industry. In 1989, the company shifted from manufacturing to distribution, by acquiring Gemaire Distributors Inc., a South Florida-based Rheem distributor.

DXCM vs WSO — Head-to-Head

Bigger by revenue
WSO
WSO
1.3× larger
WSO
$1.6B
$1.3B
DXCM
Growing faster (revenue YoY)
DXCM
DXCM
+31.6% gap
DXCM
21.6%
-10.0%
WSO
Higher net margin
DXCM
DXCM
16.7% more per $
DXCM
21.2%
4.5%
WSO
Faster 2-yr revenue CAGR
DXCM
DXCM
Annualised
DXCM
12.0%
0.4%
WSO

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
DXCM
DXCM
WSO
WSO
Revenue
$1.3B
$1.6B
Net Profit
$267.3M
$71.7M
Gross Margin
62.9%
27.1%
Operating Margin
25.6%
6.4%
Net Margin
21.2%
4.5%
Revenue YoY
21.6%
-10.0%
Net Profit YoY
153.6%
-25.9%
EPS (diluted)
$0.67
$1.82

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DXCM
DXCM
WSO
WSO
Q1 26
$1.3B
Q4 25
$1.3B
$1.6B
Q3 25
$1.2B
$2.1B
Q2 25
$1.2B
$2.1B
Q1 25
$1.0B
$1.5B
Q4 24
$1.1B
$1.8B
Q3 24
$994.2M
$2.2B
Q2 24
$1.0B
$2.1B
Net Profit
DXCM
DXCM
WSO
WSO
Q1 26
$267.3M
Q4 25
$267.3M
$71.7M
Q3 25
$283.8M
$161.6M
Q2 25
$179.8M
$183.6M
Q1 25
$105.4M
$80.1M
Q4 24
$151.7M
$96.8M
Q3 24
$134.6M
$171.0M
Q2 24
$143.5M
$181.4M
Gross Margin
DXCM
DXCM
WSO
WSO
Q1 26
62.9%
Q4 25
62.9%
27.1%
Q3 25
60.5%
27.5%
Q2 25
59.5%
29.3%
Q1 25
56.9%
28.1%
Q4 24
58.9%
26.7%
Q3 24
59.7%
26.2%
Q2 24
62.4%
27.1%
Operating Margin
DXCM
DXCM
WSO
WSO
Q1 26
25.6%
Q4 25
25.6%
6.4%
Q3 25
20.1%
11.4%
Q2 25
18.4%
13.2%
Q1 25
12.9%
7.3%
Q4 24
17.0%
7.8%
Q3 24
15.3%
11.6%
Q2 24
15.7%
12.6%
Net Margin
DXCM
DXCM
WSO
WSO
Q1 26
21.2%
Q4 25
21.2%
4.5%
Q3 25
23.5%
7.8%
Q2 25
15.5%
8.9%
Q1 25
10.2%
5.2%
Q4 24
13.6%
5.5%
Q3 24
13.5%
7.9%
Q2 24
14.3%
8.5%
EPS (diluted)
DXCM
DXCM
WSO
WSO
Q1 26
$0.67
Q4 25
$0.67
$1.82
Q3 25
$0.70
$3.98
Q2 25
$0.45
$4.52
Q1 25
$0.27
$1.93
Q4 24
$0.37
$2.42
Q3 24
$0.34
$4.22
Q2 24
$0.35
$4.49

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DXCM
DXCM
WSO
WSO
Cash + ST InvestmentsLiquidity on hand
$917.7M
$733.3M
Total DebtLower is stronger
$361.6M
Stockholders' EquityBook value
$2.7B
$2.8B
Total Assets
$6.3B
$4.4B
Debt / EquityLower = less leverage
0.13×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DXCM
DXCM
WSO
WSO
Q1 26
$917.7M
Q4 25
$917.7M
$733.3M
Q3 25
$1.8B
$524.3M
Q2 25
$1.2B
$293.0M
Q1 25
$904.9M
$431.8M
Q4 24
$606.1M
$781.9M
Q3 24
$621.2M
$550.0M
Q2 24
$939.2M
$424.9M
Total Debt
DXCM
DXCM
WSO
WSO
Q1 26
Q4 25
$361.6M
Q3 25
$340.8M
Q2 25
$338.7M
Q1 25
$346.4M
Q4 24
$337.2M
Q3 24
$321.0M
Q2 24
$307.1M
Stockholders' Equity
DXCM
DXCM
WSO
WSO
Q1 26
$2.7B
Q4 25
$2.7B
$2.8B
Q3 25
$2.7B
$2.8B
Q2 25
$2.6B
$2.8B
Q1 25
$2.3B
$2.7B
Q4 24
$2.1B
$2.7B
Q3 24
$2.0B
$2.7B
Q2 24
$2.4B
$2.6B
Total Assets
DXCM
DXCM
WSO
WSO
Q1 26
$6.3B
Q4 25
$6.3B
$4.4B
Q3 25
$7.5B
$4.6B
Q2 25
$7.3B
$4.7B
Q1 25
$6.8B
$4.5B
Q4 24
$6.5B
$4.5B
Q3 24
$6.4B
$4.5B
Q2 24
$6.8B
$4.4B
Debt / Equity
DXCM
DXCM
WSO
WSO
Q1 26
Q4 25
0.13×
Q3 25
0.12×
Q2 25
0.12×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.12×
Q2 24
0.12×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DXCM
DXCM
WSO
WSO
Operating Cash FlowLast quarter
$399.8M
Free Cash FlowOCF − Capex
$388.5M
FCF MarginFCF / Revenue
24.6%
Capex IntensityCapex / Revenue
0.7%
Cash ConversionOCF / Net Profit
5.57×
TTM Free Cash FlowTrailing 4 quarters
$535.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DXCM
DXCM
WSO
WSO
Q1 26
Q4 25
$294.0M
$399.8M
Q3 25
$659.9M
$354.9M
Q2 25
$303.0M
$-7.4M
Q1 25
$183.8M
$-177.6M
Q4 24
$301.4M
$378.9M
Q3 24
$199.5M
$232.8M
Q2 24
$279.4M
$57.7M
Free Cash Flow
DXCM
DXCM
WSO
WSO
Q1 26
Q4 25
$192.1M
$388.5M
Q3 25
$579.4M
$346.1M
Q2 25
$208.9M
$-14.3M
Q1 25
$96.8M
$-185.2M
Q4 24
$176.8M
$370.9M
Q3 24
$88.3M
$223.0M
Q2 24
$213.3M
$51.3M
FCF Margin
DXCM
DXCM
WSO
WSO
Q1 26
Q4 25
15.3%
24.6%
Q3 25
47.9%
16.7%
Q2 25
18.1%
-0.7%
Q1 25
9.3%
-12.1%
Q4 24
15.9%
21.1%
Q3 24
8.9%
10.3%
Q2 24
21.2%
2.4%
Capex Intensity
DXCM
DXCM
WSO
WSO
Q1 26
Q4 25
8.1%
0.7%
Q3 25
6.7%
0.4%
Q2 25
8.1%
0.3%
Q1 25
8.4%
0.5%
Q4 24
11.2%
0.5%
Q3 24
11.2%
0.5%
Q2 24
6.6%
0.3%
Cash Conversion
DXCM
DXCM
WSO
WSO
Q1 26
Q4 25
1.10×
5.57×
Q3 25
2.33×
2.20×
Q2 25
1.69×
-0.04×
Q1 25
1.74×
-2.22×
Q4 24
1.99×
3.91×
Q3 24
1.48×
1.36×
Q2 24
1.95×
0.32×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons